Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Taeko Matsushima"'
Autor:
Yasufumi Kaneda, Takashi Shimbo, Kotaro Saga, Tomoyuki Nishikawa, Liu Li-Wen, Motonari Nomura, Koji Hatano, Taeko Matsushima-Miyagi
PDF file - 395K, Figure S1. Selective apoptosis in DU145 cells induced by HVJ-E. Figure S2. The effect of poly (I:C) on cell survival. Figure S3. No significant changes in the expression of Bax, Puma, Bcl-xL or Bcl-2 were observed in cells treated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::182f4f8ab32888f05f6a4dbcf2d510be
https://doi.org/10.1158/1078-0432.22447592
https://doi.org/10.1158/1078-0432.22447592
Autor:
Yasufumi Kaneda, Takashi Shimbo, Kotaro Saga, Tomoyuki Nishikawa, Liu Li-Wen, Motonari Nomura, Koji Hatano, Taeko Matsushima-Miyagi
Purpose: The treatment of cancer with oncolytic viruses primarily depends on the selective viral replication in cancer cells. However, a replication-incompetent hemagglutinating virus of Japan (HVJ; Sendai virus) envelope (HVJ-E) suppresses the growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa4b742b058ae69d21324253781226b
https://doi.org/10.1158/1078-0432.c.6521132
https://doi.org/10.1158/1078-0432.c.6521132
Autor:
Yoshimi Ishido, Shoji Nagao, Miho Kitai, Takashi Shibutani, Tomoatsu Jimi, Satoshi Yamaguchi, Kasumi Yamamoto, Kazuhiro Suzuki, Kazuko Matsuoka, Hiroko Yano, Moyu Narita, Hiroshi Nakazawa, Taeko Matsushima, Tomoharu Tsu, Takaya Shiozaki
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 47:1536-1543
Aim Cell-free and concentrated ascites reinfusion therapy (CART) is applied to relieve symptoms in patients with malignant ascites. We performed a prospective cohort study to evaluate the efficacy and safety of CART performed on patients with advance
Autor:
Kotaro Saga, Taeko Matsushima-Miyagi, Yasufumi Kaneda, Tomoyuki Nishikawa, Koji Hatano, Takashi Shimbo, Liu Li-Wen, Motonari Nomura
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 18(22)
Purpose: The treatment of cancer with oncolytic viruses primarily depends on the selective viral replication in cancer cells. However, a replication-incompetent hemagglutinating virus of Japan (HVJ; Sendai virus) envelope (HVJ-E) suppresses the growt